期刊文献+

血清与脑脊液唾液酸含量测定对脑瘤与脊髓瘤诊断价值的比较 被引量:3

Diagnostic value and clinical significance of sialic acid in serum and CSF of patients with brain and spinal cord tumor
暂未订购
导出
摘要 目的检测脑瘤与脊髓肿瘤患者血清和脑脊液(CSF)中唾液酸(SA)的含量,比较两者对脑瘤与脊髓瘤的诊断价值。方法应用SA快速比色测定盒对113例脑肿瘤和24例脊髓肿瘤患者血清及CSF唾液酸含量进行测定,分别进行组间比较。结果脑瘤与脊髓瘤患者血清和CSF唾液酸含量明显高于对照组(P<0.01和P<0.001),而CSF中SA含量的阳性率(92.7%)明显高于血清SA含量的阳性率(60.6%),两者有显著性差异(P<0.001)。结论血清和CSF中SA含量可作为脑瘤与脊髓瘤的诊断指标之一,而CSF中SA含量的测定对脑瘤与脊髓瘤的诊断更具临床价值。 Objective To study the diagnostic value of sialic acid in the serum and cerebrospinal fluid (CSF) of patients with brain and spinal tumor.Methods The total sialic acid fast test kit was used to measure levels of sialic acid in the serum and CSF of 113 patients with brain tumor and 24 patients with spinal cord tumor,and the results were compared with those of the control group and each other.Results The sialic acid levels in the serum and CSF of patients with brain and spinal cord tumor were significantly higher than those of control group ( P <0.01),and the patients with malignant tumor had higher sialic acid levels than those with benign tumor ( P <0.01).Conclusions Concentration of sialic acid in the serum and CSF can serve as an index of the diagnosis of brain and spinal cord tumor and the determination of the nature of the tumor,but the sialic acid test of CSF of patients with brain and spinal cord tumor was more valuable than that of serum of patients with brain and spinal cord tumor ( P <0.01).
出处 《实用肿瘤杂志》 CAS 北大核心 1999年第1期18-19,共2页 Journal of Practical Oncology
关键词 唾液酸 血清 脊髓肿瘤 脑脊 脑肿瘤 sialic acids/blood sialic acids/cerebrospinal fluid spinal cord neoplasms/cerebrospinal fluid brain neoplasms/blood brain neoplasms/cerebrospinal fluid
  • 相关文献

参考文献10

二级参考文献6

共引文献14

同被引文献27

  • 1文芳,李承晏.脑脊液唾液酸含量测定对脑和脊髓肿瘤诊断价值的探讨[J].癌症,1997,16(2):134-135. 被引量:3
  • 2Kayaselcuk F,Zorludemir S,Gumurdulu D,et al.PCNA and Ki-67 in central nervous system tumors:correclation with the histological and grade.J Neurooncol,2002;57:115~121
  • 3Reavey-Cantwell JF,Haroun RI,Zahurak M,et al.The prognostic value of tumor markers in patients with glioblastoma multiforme:analysis of 32 patients and review of the literature.J Neurooncol,2001;55:195~204
  • 4Huang FH,Kanno HS,Yamamotol I,et al.Correlation of clinical features and telomerase activity in human gliomas.J Neurooncol,1999;43:137~142
  • 5Falchetti ML,Pallini R,Larocca LM,et al.Telomerase expression in intracranial tumours:prognostic potential for malignant gliomas and meningiomas.J Clin Pathol,1999;52:234~236
  • 6Iny V,Edwards V,Halliday W,et al."Ployphenotypic" tumors in the central nervous system:problems in nosology and classification.Pedictr Pathol Lab Med,1997;17(3):369~389
  • 7Maity A,Pore N,Lee J,et al.Epidermal growth factor recepor transcriptionally upregulates vascular endothelial growth factor expression in human glioblastoma cells via a pathway in-kinase and distinct from that volving phoshatidylinositol3*induced by hypoxial.Cancer Res,2000;60:5879~5886
  • 8Jin W,Xu X,Yang T,et al.p53 mutation,EGGR gene amplification and loss of heterozygosity on chromosome 10,17p in human gliomas.Chin Med J(Engl),2000;113(7):662~666
  • 9Schiebe M,Ohneseit P,Hoffmann W,et al.Loss of heterozygosity at 1 1p15 and p53 alterations in malignant gliomas.J Cancer Res Clin Oncol,2001;127(5):325~328
  • 10Kato H,Kato S,Kumabe T,et al.Functional evaluation of p53 and PTEN gene mutations in gliomas.Clin Cancer Res,2000;6(10):3937~3943

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部